07:00 , Mar 30, 2015 |  BioCentury  |  Analyst Picks & Changes

Analyst picks & changes

Analyst picks & changes Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 3/27 cls Exact Sciences Corp. (NASDAQ:EXAS) Goldman Sachs Isaac Ro Downgrade Neutral (from buy) -7% $22.49 Ro also lowered his...
08:00 , Feb 23, 2015 |  BioCentury  |  Analyst Picks & Changes

Analyst picks & changes

Analyst picks & changes Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 2/20 cls Eagle Pharmaceuticals Inc. (NASDAQ:EGRX) Cantor Fitzgerald Irina Rivkind Koffler Price target Buy 61% $33.68 William Blair Tim Lugo...
08:00 , Jan 26, 2015 |  BioCentury  |  Analyst Picks & Changes

Analyst picks & changes

Analyst picks & changes Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 1/23 cls Arrowhead Research Corp. (NASDAQ:ARWR) Deutsche Bank Alethia Young Downgrade Hold (from buy) -6% $6.43 Young also lowered her...
07:00 , Sep 22, 2014 |  BioCentury  |  Analyst Picks & Changes

Analyst picks & changes

Analyst picks & changes Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 9/19 cls Auxilium Pharmaceuticals Inc. (NASDAQ:AUXL) Leerink Partners Joseph Schwartz Downgrade Market perform (from outperform) 39% $31.14 UBS Marc Goodman...
07:00 , Jul 21, 2014 |  BioCentury  |  Analyst Picks & Changes

Analyst picks & changes

Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 7/18 cls Genfit S.A. (Euronext:GNFT) Deutsche Bank Alethia Young New Buy 23% €29.50 Young initiated coverage with a €110 target on the potential of...
07:00 , Mar 13, 2014 |  BC Innovations  |  Distillery Therapeutics

Indication: Musculoskeletal disease

Indication Target/marker/pathway Summary Licensing status Publication and contact information Musculoskeletal disease Osteoporosis Sialic acid binding Ig-like lectin 15 (SIGLEC15) Cell-based and mouse studies suggest inhibition of SIGLEC15 could help prevent osteoclast-mediated bone destruction in osteoporosis...
08:00 , Jan 27, 2014 |  BioCentury  |  Analyst Picks & Changes

Analyst picks & changes

Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 1/17 cls AMAG Pharmaceuticals Inc. (NASDAQ:AMAG) Jefferies Eun Yang Upgrade Hold (from underperform) -3% $21.01 Ladenburg Thalmann Juan Sanchez Downgrade Neutral (from buy) Yang...
07:00 , Oct 7, 2013 |  BioCentury  |  Analyst Picks & Changes

Analyst picks & changes

Analyst picks & changes Wk 10/4 Company Bank Analyst Coverage Opinion chg cls Achillion Pharmaceuticals Inc. (NASDAQ:ACHN) Baird Brian Skorney Downgrade Neutral (from outperform) -62% $2.72 Deutsche Bank Alethia Young Downgrade Hold (from buy) Piper...
07:00 , Jun 24, 2013 |  BioCentury  |  Analyst Picks & Changes

Analyst picks & changes

Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 6/21 cls Elan Corp. plc (NYSE:ELN) Jefferies Corey Davis Price target Buy 2% $13.98 Davis raised his target from $14 to reflect his belief...
07:00 , Jun 3, 2013 |  BC Week In Review  |  Company News

Alethia, International Biotech Center (IBC) Generium deal

Alethia and IBC Generium partnered to co-develop Alethia's AB-16B5 , an IgG2 mAb against clusterin (CLU; APOJ ) in preclinical testing for cancer. Alethia will receive an upfront cash payment and R&D funding to conduct...